BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Debt History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Debt | ₹23 Cr | ₹11 Cr | ₹13 Cr | ₹3.02 Cr | ₹46 Cr |
What is the latest Total Debt ratio of BAFNA PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2023 | ₹23 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹13 Cr |
Mar2020 | ₹3.02 Cr |
Mar2019 | ₹46 Cr |
How is Total Debt of BAFNA PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2023 | ₹23 Cr | 107.27 | |
Mar2022 | ₹11 Cr | -14.92 | |
Mar2021 | ₹13 Cr | 330.75 | |
Mar2020 | ₹3.02 Cr | -93.47 | |
Mar2019 | ₹46 Cr | - |
Compare Total Debt of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹253.0 Cr | 16.9% | 31.2% | -1.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 16.9% |
31.2% |
-1.1% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses